ExpreS2ion Biotech Holding AB (FRA:5JD0) FFO


FRA:5JD0 ExpreS2ion Biotech Holding AB FRA:5JD0
43 GF Score
Price €0.04
GF Value €0.09
! 5 Warning Signs
View Full Analysis

What is ExpreS2ion Biotech Holding AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:5JD0
43GF Score
ExpreS2ion Biotech Holding AB FRA:5JD0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ExpreS2ion Biotech Holding AB (FRA:5JD0) Overvalued in 2026?

Based on GuruFocus' analysis, ExpreS2ion Biotech Holding AB stock appears to be undervalued. The current stock price of €0.04 is trading 58.7% below its estimated GF Value™ of €0.09.

Key valuation signals for FRA:5JD0:

  • FFO:
  • GF Value™: €0.09 vs. price of €0.04 (58.7% below fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the FRA:5JD0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ExpreS2ion Biotech Holding AB Business Description

Other Exchanges EXPRS2:Sweden
Address c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, 252 25
ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.
43GF Score

Get the complete analysis for FRA:5JD0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.04
Price
€0.09
GF Value